In this video, Dr. Paul Schellhammer discusses recent research that suggests that active immunotherapy could be used to treat earlier stages of prostate cancer and shares his perspective about what he believes this means for men with less advanced disease. Dr. Schellhammer also explains how this research changes the landscape of treatment and what he feels are developing areas of hope for men with men with advanced and/or metastatic disease.